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Abstract
Iontophoresis allows for localized drug ejections di-
rectly into brain regions of interest driven by the
application of current. Our lab has previously adapted
amethod to quantitatively monitor iontophoretic ejec-
tions. Here those principles have been applied in vivo to
modulate electrically evoked release of dopamine in
anesthetized rats. A neutral, electroactive marker mole-
cule that is ejected purely by electroosmotic flow (EOF)
was used to monitor indirectly the ejection of electro-
inactive dopaminergic drugs (raclopride, quinpirole, and
nomifensine). Electrode placements were marked with
an iontophoretically ejected dye, pontamine sky blue.
We show that EOF marker molecules, acetaminophen
(AP) and 2-(4-nitrophenoxy) ethanol (NPE), have no
effect on electrically evoked dopamine release in the
striatum or the sensitivity of electrode. Additionally,
we establish that a short, 30 s ejection of raclopride,
quinpirole, or nomifensine with iontophoresis is suffi-
cient to affect autoreceptor regulation and the reuptake
of dopamine. These effects vary in lifetime, indicating
that this technique can be used to study receptor kinetics.
Keywords: Iontophoresis, fast-scan cyclic voltammetry,
dopamine, carbon fiber, quantitative, presynaptic
I
ontophoresis was first developed byW. L.Nastuk,
a student of A. L. Hodgkin, who was interested in
how the actions of acetylcholine (ACh) on the
neuromuscular junction were altered with changes in
the ionic composition of the extracellular bath solu-
tion (1). His previous studies with intracellular pipet
recordings led him to the discovery that if pipets were
pulled to a coarse tip and then filled with ACh, some
ACh would slowly diffuse out. He expanded on this
observation and decided to electrically control delivery
of ACh through the glass pipettes, and thus iontophor-
esis was born in 1953 (2). Recognizing that fast and
controlled delivery of ACh could be used to search and
map end-plate regions on the neuromuscular region,
many researchers, including del Castillo and Katz, used
it to study the actions of ACh on synaptic sites (3-6).
The first studies using iontophoresis in the central
nervous system were made by Eccles and Curtis who
were interested in studying Renshaw cells and used the
first account of a multibarrel iontophoresis probe to
locate and modulate cells (7-9).
Throughout the remainder of the 1950s and into the
1970s, iontophoresis grew in popularity, and important
contributions concerning the advantages and disadvan-
tages of iontophoretic drugdeliveryweremade (10-19).
The techniquewas (and is) favored for studying receptor
dynamics in vivo because drugs can be quickly, selec-
tively, and locally delivered to the site (or sites) of action.
Traditional methods of pharmacological intervention,
such as intraperitoneal or intravenous delivery, affect
the entire brain and can confound interpretation of the
measured results. Furthermore, only drugs that can pass
the blood-brain barrier can be used for systemic drug
delivery, and even then, metabolism of the drug may
reduce its effects (15). Iontophoresis circumvents all of
these problems, making it very attractive for pharma-
cological neurobiology studies.
However, despite the clear advantages of iontophor-
esis, challenges with reproducibility and quantitation of
drug delivery have prevented the technique from being
more widely used (3, 11, 13, 15, 18-23). A major draw-
back of iontophoresis as it has been previously used is
that there is no way to differentiate between an unre-
sponsive site and a faulty drug ejection. Recently, we
modified the design of Millar and co-workers, coupling
iontophoresis barrels to carbon-fibermicroelectrodes to
allow the concentrations of electroactive compounds
deliveredby iontophoresis to bemonitoredwith fast-scan
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cyclic voltammetry (22). While characterizing ionto-
phoretic delivery, we found that electroosmosis contri-
butes significantly to the observed drug delivery. Electro-
osmosis is due to ionizable silanol groups on the glass
capillary surface, which attract cations in solution to
form an electrical double layer. When a positive current
is applied to the capillary, the cations along the wall
migrate toward the anode (outside of the capillary),
creating a bulk movement of solution, termed electro-
osmotic flow (EOF). Thus, iontophoretic delivery is
governed by the traditional mechanism attributed to
iontophoresis, ion migration, and EOF. In addition, we
showed that an electroactive neutral molecule could
serve as an internal standard to monitor the variability
in the amount of drug delivered from different barrels.
These insights into the iontophoresis technique enable
quantitative delivery of electroactive and electroinactive
drugs bymonitoring the ejection of an electroactive EOF
marker (24).
Although fast-scan cyclic voltammetry has been pre-
viously combined with iontophoresis for neurophysiol-
ogy experiments, it has not been used to modulate
presynaptic release of neurotransmitters (25-31). In
this paper, we demonstrate the use of quantitative
iontophoresis for the modulation of dopamine release
in the striatum of anesthetized rats. We characterize
ejections in vivo with particular emphasis on leakage
and the time course of drug ejection. We also have
tested the effects on dopamine release upon applica-
tion of two electroactive marker molecules, AP and
NPE, to ensure that our method of quantitation does
not alter the biological system. Expanding on our
previous work, we have quantified the relative mobi-
lities of drugs of pharmacological interest that are not
electroactive. Finally, we demonstrate that dopamine
neurotransmission can be locally modulated at termi-
nals by affecting D2 autoreceptors and the dopamine
transporter.
Results and Discussion
Characterization of Iontophoretic Delivery in Vivo
Traditionally, iontophoretic ejection of substances
with constant current has been consideredas continuous
electrical migration of an ion out of the pipet tip
followed by diffusion into the surrounding environ-
ment (32). Theoretical and experimental calculations
predict that migration out of the pipet tip will be
influenced by the prior history of the pipet including
the magnitude of the retaining current applied and the
frequency of previous ejections (18, 19). Our previous
work showed that the iontophoretic barrels that we
construct have sufficiently small leakage that it is im-
measurable by the adjacent carbon-fiber microele-
ctrode (24). However, we observe that the first few
ejections have diminished ejection efficiency, presum-
ablydue to leakageduring the time for implantation and
stabilization of the electrode (∼1 h). This is shown in
Figure 1, where the local AP concentration was mon-
itored at the peak current of its oxidation during fast-
scan cyclic voltammetry as it was ejected into the
striatum of an anesthetized rat. The time course during
30 s ejections is shown in Figure 1A. The voltammetric
response increases when the iontophoretic current is
initiated. The response continues to increase as the
ejection continues and reaches a steady state. As shown,
the time to reach a steady state is longer for the first
ejection than the subsequentones.This delay is the likely
cause of the “warm-up phenomenon” noted in previous
studies where initial iontophoretic ejections elicited little
to no biological response, but with subsequent ejections
the response grew in over time (17). For this reason,
before beginning biological studies, we “warm up” the
electrode by continuously ejecting for 2-5 min into an
area of the brain that is not of interest. Figure 1B shows
the reproducibility of ejections after the “warm-up”
period. Ten consecutive ejections for a single barrel
show a similar steady-state level compared with the first
ejection after the warm-up period (n=5). However, to
Figure 1. Temporal profile of consecutive iontophoretic ejections.
(A) Current vs time trace for the first three ejections of AP in the rat
brain. Ejection current was turned on at t= 0 s and off at t= 30 s.
Ejection 1 shows a characteristic delay in rise time, consistent with a
“warm-up” period for ejections. Subsequent ejections, 2 and 3, have
less of a delay, and ejection 3 reaches steady state. (B) 10 consecutive
ejections into PBS buffer after “warm-up” period. [AP]/[AP]1 repre-
sents the amount of AP measured at steady state compared with the
amount measured from the first ejection after the “warm-up” period.
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take advantage of the finely controlled drug delivery
enabled by iontophoresis, we are interested in monitor-
ing the biological effects of a single 30 s ejection and thus
may not always reach this steady state at the site of
interest, as will be evident later.
For a substance monitored by cyclic voltammetry
with the carbon fiber, the amplitude of the voltammetric
current is expected to increase as the ejected substance
diffuses from the ejection point down the length of the
fiber and to remain constant once the diffusion distance
exceeds the electrode length. The concentration mea-
sured is actually the average concentration along the
length of the electrode determined by a gradient started
at the iontophoretic tip, where the concentration is close
to that in the barrel (10mM). For example, an electrode
with a length of 30 μm (as in Figure 1) reports a current
that is proportional to a uniform concentration of 3 μM
across the surface of the electrode once steady state is
reached.When the iontophoretic current is turnedoff, the
analyte quickly diffuses away from the electrode. Within
120 s, the iontophoresed substance can still be detected
voltammetrically, but it has diluted to a concentration
that is ∼2% of its steady-state value during ejection.
Effects of EOFMarker on Stimulated Dopamine
Release
A common way to probe presynaptic factors that
regulate neurotransmitter release is to examine the
effects of added pharmacological agents on electrically
evoked release (33-35). For example, the role of auto-
receptors can be probed by examining stimulations
before and after addition of receptor antagonists. How-
ever, before the iontophoretic method was used with
electrical stimulation to probe presynaptic events at
dopaminergic terminals, we had to ensure that delivery
of the neutral marker substances did not affect dopa-
mine release. In these experiments, AP or NPE was
delivered for 30 s, followed by a wait-period of 120 s
before electrical stimulation of the medial forebrain
bundle (MFB). Figure 2 shows the results of a typical
experiment in a urethane anesthetized rat. A carbon-
fiber/iontophoresis probe was lowered into the striatum
and a stimulating electrode was lowered into the MFB.
Stimulated release (60 Hz, 40 pulses) was evoked every
120 s until 10 consecutive maximal stimulations showed
a similar maximal concentration (typically requiring 15
stimulations). A representative baseline trace and color
plot are shown in Figure 2A. To test the effects of the
EOF marker on dopamine release, AP was iontophor-
etically applied for 30 s at a location that exhibited
reproducible stimulated release. The amount of AP
delivered was monitored electrochemically, and the
concentration versus time trace and color plot are
shown in Figure 2B. Stimulation was repeated 120 s
after AP delivery, and the maximum amplitude of
released dopamine and its time course remained the
Figure 2. Effect of AP on stimulated dopamine release. The top panels show current as a function of time while the lower panels are two-
dimensional color plots where current is shown in false color on the potential vs time axes. The white dashed lines on the color plots indicate the
voltages at which oxidation (lower lines) and reduction (top lines) is occurring. (A)A representative baseline current trace and color plot for the
stimulated release of dopamine. The black dashed line (t = 0) indicates time of stimulation. (B) Representation of iontophoretic ejection of
3 μM AP. The black dashed line (t = 0) indicates the application of a positive current to the barrel. (C) Current trace and color plot for
stimulated release after ejection seen in panel B. The black dashed line (t = 0) indicates time of stimulation. There is no change in the extra-
cellular concentrations of dopamine seen in panels A and C elicited with a stimulation indicated by the black dashed line and t=0 for each trace.
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same. From the concentration of AP during its ionto-
phoresis, 3 μM,we can estimate the concentration at the
time of the stimulation to be 60 nM (2% of the steady-
state level). Stimulations were continued at 2 min inter-
vals for 30 min, and there was no significant change in
the amount of dopamine released or rate of reuptake
(Figure 2C, n= 9, p>0.01). The same experiment was
performed for NPE, with no measurable difference
observed from control (n= 4, p>0.01).
Current Artifacts on Stimulated Dopamine Re-
lease
It is often noted in iontophoretic literature that
current artifacts can be seen neurophysiologically due
to the introduction of Naþ and Cl- that are in the drug
solution (13, 23). Although in our experiments we are
not monitoring cell firing and are instead monitoring
presynaptic release of dopamine, we wanted to ensure
that current artifacts were not affecting our measured
results. For these experiments, just as in the previous set
of experiments, we adjusted the position of the carbon
fiber/iontophoresis assembly so that it was in a location
in the striatum that showed robust dopamine release.
After establishing reproducible stimulated release of
dopamine, we iontophoretically ejected NaCl (5 mM
in the barrel, made up in deionized water) for 30 s.
Although NaCl is not electroactive, by applying a large
constant current (80 nA) we are able to detect a change
in our background signal (∼4 nA in this example) that
evolves with time (Figure 3). The current is an indirect
effect of the iontophoresis and its time course indicates
that it reflects a change in the electrical double layer
formed at the carbon-fiber electrode. While we cannot
quantify the amount of NaCl delivered from this signal,
it does serve to confirm that ejection occurred. Stimu-
lated dopamine release was then measured 120 s after
the NaCl ejection was terminated to ensure that it did
not alter presynaptic release dynamics. The results from
this experiment indicate that stimulated dopamine re-
lease is unaffected by large ejections of NaCl and are
shown in Figure 3 (n = 4, p >0.05). The NaCl ejected
with large currents does alter the double layer of the
carbon fiber, although this is not seen with the lower
ejection currents typically used.
Marking of Electrode Placement by Iontophoresis
of a Dye
When dealing with small brain structures, it is crucial
to know the location of the electrode.A commonway to
verify electrode placement is to remove the brain after
the experiment is over for histology. For experiments
using carbon-fiber microelectrodes, one approach is to
electrolytically lesion the electrode. This has the short-
coming that the carbon fiber is destroyed during this
Figure 3. Effect of saline on stimulated dopamine release. The top panels show current as a function of time, while the lower panels are two-
dimensional color plots where current is shown in false color on the potential vs time axes. The white dashed lines on the color plots in panels A
and C indicate the voltages at which oxidation (lower lines) and reduction (top lines) is occurring, whereas in panel B, the dashed white line
indicates the potential change observed due to the ejection ofNaCl. (A)A representative baseline current trace and color plot for the stimulated
release of dopamine. The black dashed line (t=0) indicates time of stimulation. (B)Representation of iontophoretic ejection of salinewith high
applied current. The black dashed line (t= 0) indicates the application of a positive current to the barrel. (C) Current trace and color plot for
stimulated release after ejection seen in panel B. The black dashed line (t = 0) indicates time of stimulation. There is no change in the
extracellular concentrations of dopamine seen in panelsA andC elicitedwith a stimulation indicated by the black dashed line and t=0 for each
trace.
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process and cannot be calibrated after the in vivo
experiment. An alternate approach is to remove the
electrode after the experiment for calibration and insert
a tungsten wire to electrically mark the location of the
previous electrode. Iontophoresis barrels provide a
more convenient and precise method to mark electrode
placement. Figure 4 shows the marking of electrode
placement by delivering pontamine sky blue dye ionto-
phoretically for 20 min at 40 nA once the experiment
was over. The length of ejection was chosen to ensure
that a large enough spot was produced, given that
iontophoresis is such a localized drug delivery mechan-
ism.Byusing ofoneof the emptybarrels todeliver a dye,
the electrode placement can be accurately determined,
while keeping the carbon fiber intact forpostcalibration.
Manyother dyes canbeused, such as alcianblue,methyl
blue, fast green, and lucifer yellow, making the proce-
dure compatible with any other immunohistochemistry
that may be done postexperiment (23).
Quantitative Iontophoresis of Nonelectroactive
Drugs
In our previous work, relative iontophoretic mobili-
ties at capillary tips were obtained for electroactive
molecules bymeasuring the ejected amounts at the adja-
cent carbon-fiber microelectrode (24). We found that
neutralmolecules such asAPcanbeejected, establishing
a role for EOF. We also established the role of EOF by
demonstrating that iontophoretic and electrophoretic
mobilities measured via capillary electrophoresis are
correlated. Thus, at the tip of an iontophoresis pipet,
delivery is controlled by both the migration of ions in
an electric field and EOF. To obtain the iontopho-
retic mobility of electroinactive molecules such as the
dopaminergic drugs raclopride, quinpirole, and nomi-
fensine (structures shown inFigure 5), the electrophoretic
mobility through a capillary column was measured with
UV detection. Retention times were used to compute the
electrophoretic mobilities for dopamine, raclopride,
quinpirole, nomifensine (all monocations), AP (a neutral
molecule), and uric acid (a monoanion). The electro-
phoreticmobilitieswere thenused to calculate the relative
iontophoretic mobilities as shown in Figure 6. Thus,
raclopride is ejected at a rate 1.68 times as fast as
AP,whereas quinpirole and nomifensine are ejected at
a rate 2.18 and 2.24 times as fast as AP, respectively.
With the knowledge of these ratios, the amount of an
electroinactive molecule that is ejected can be calcu-
lated by the measured coejection of a neutral electro-
active molecule from the same barrel. Note that the
relative mobilities are in agreement with the expected
charge (calculated from the relevant pKa’s) and the
size of the molecules.
With an average ejection and an electrode with a
length of 30 μm, the average concentration ofAP across
the carbon fiber is 3 μM for the example shown in
Figure 2. However, the concentration at the portion of
the carbon fiber closest to the iontophoresis tip is very
near that placed inside the barrel (10 mM). Such high
concentrations of drug could alter the sensitivity of the
Figure 4. Confirmation of electrode placement into the striatum
using iontophoresis of pontamine sky blue dye. After a 20 min
ejection, the spot is 600 μm in diameter. Left side of the figure shows
region of interest labeled and circledwith a dashed line. On the right,
the spot from the ejection of dye can be seen in the circled region of
interest.Adaptedwith permission from ref 45. Copyright 2007Elsevier.
Figure 5. Chemical structures of compounds used for study. Shown
are compounds with their associated anions. At pH 5.8, raclopride,
nomifensine, quinpirole, and dopamine are all protonated based
upon their pKa’s obtained on Scifinder. All solutions were made up
as 10 mM in 5 mM NaCl to ensure adequate electroosmotic flow
and for buffering of the ionic strength.
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electrode to dopamine. To evaluate this, we first cali-
brated a series of carbon-fiber iontophoresis probes to
determine their sensitivity to dopamine.We then loaded
one of the iontophoresis barrels with the EOF marker
(AP) orAP and a drug of interest.Whilemonitoring the
response ofAPwith the carbon-fibermicroelectrode,we
continuously ejected the mixture into buffer for 40 min
with a pump current sufficient to deliver approximately
10 μMof AP. After the 40 min ejection and monitoring
period, we calibrated the carbon-fiber electrodes’ sensi-
tivity to dopamine again and determined the ratio of the
electrodes’ post-iontophoresis sensitivity to pre-ionto-
phoresis sensitivity. The results from these experiments
are presented in Table 1. AP and NPE, which are both
neutral and can be used as EOF markers, did not
significantly alter the electrodes’ response to dopamine.
Pharmacological agents, such as nomifensine, quinpir-
ole, and raclopride, have slight effects on the electrodes’
response to dopamine. Note, however, that the ejection
times used during these iontophoresis experiments (40
min per ejection) were considerably longer than would
be used in most in vivo experiments (normally 30 s per
ejection).Given the small effect observed, evenwith these
prolonged iontophoresis conditions, the results demon-
strate that iontophoresis of these drugs during in vivo
experiments will not affect our dopamine measurements.
Modulation of Neurotransmitter Release Using
Quantitative Iontophoresis
Dopamine release from terminals in the striatum is
regulated by D2-autoreceptors (34). Quinpirole, a D2-
agonist, has been shown to decrease stimulated dopamine
release in slices (36), and we wanted to show in vivo
modulation with iontophoretic application of quinpirole.
For these experiments, we adjusted the position of the
carbon fiber/iontophoresis assembly so that it was in a
location in the striatum that showed robust dopamine
release (37). After establishing reproducible stimulated
release of dopamine, we iontophoretically ejected quin-
pirole andAP from the same barrel for 30 s. The local AP
concentration was monitored by fast-scan cyclic voltam-
metry. The stimulation was repeated 120 s after the
iontophoretic delivery terminated when AP had dimin-
ished to ∼2% of its concentration during iontophoretic
application. From the AP concentration we can calculate
that the local quinpirole concentration at the time of the
stimulation was 88 nM. This value is near the EC50
(60 nM) for quinpirole measured in brain slices (38).
Consistent with autoreceptor regulation, dopamine
releasewasdiminished (representativeexample inFigure7).
This experiment was repeated in six different rats with a
different iontophoretic assembly in each animal. In
these experiments, the amount of current used for
ejection was adjusted so that the same amount of AP
(and thus quinpirole) was ejected in each animal. The
release amplitude was 63%( 5% (n=6) of its predrug
value. The small error associated with these measure-
ments highlights the advantage of using an electroactive
marker, since it allows for adjustment to the applied
iontophoretic current so that uniform amounts of quin-
pirole are ejected. Thus, compensation can be made for
the variability inherent to each iontophoretic barrel.
Because autoreceptors and reuptake processes appear
to be linked, we also examined the clearance rates of
dopamine after stimulation.While a trend toward faster
reuptake rates was observed after quinpirole ejections,
there was not a statistically significant decrease in t1/2.
Stimulationswere repeated at 2min intervals, and the
amplitude returned to its original value within three to
five stimulations after the initial iontophoretic appli-
cation. In addition, when the electrode was lowered
400 μm, release similar to that seen in the absence of
drug was observed. Since the amounts introduced by
iontophoresis are microscopic, it would not be expected
to exert an effect over a region much larger than that
immediately around the electrode. It is worth noting
Figure 6. The electrophoretic mobilities of the electroactive com-
pounds uric acid, AP, and DA (9) are positively correlated to
previously reported iontophoretic rates. The linear regression from
this correlation was used to determined iontophoretic rates relative
to AP for raclopride (R), quinpirole (Q), and nomifensine (N) (0)
based on their electrophoretic mobilities calculated by capillary
electrophoresis.
Table 1. Effect of Iontophoresis on the Sensitivity of







AP þ NPE 1.01( 0.07
AP þ nomifensine 0.86( 0.08
AP þ quinpirole 0.91( 0.08
AP þ raclopride 0.87( 0.07
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that most iontophoresis experiments done previously
used ejections much longer than 30 s, some delivering
drug for tens of minutes (39). Such ejections seem
unnecessary in light of the results presented here. In-
deed, the ability to make multiple ejections at the same
or different sites enables multiple concentrations of
drugs to be examined in a single animal. Systemic doses
do not allow this type of flexibility, clearly highlighting
one of the major advantages of iontophoresis.
Modulation of Other Dopaminergic Presynaptic
Processes
Similar experiments were donewith raclopride, aD2-
receptor antagonist, which can block dopamine auto-
receptor function, leading to an increase in release, as
well as nomifensine, a dopamine reuptake inhibitor that
increases the amount of time required for dopamine to
clear the synapse. The results from these experiments
showed that raclopride increased stimulated dopamine
release to 270% ( 40% (n =5) of its predrug value.
Raclopride also caused a decrease in reuptake rate, as
indicated by the increased t1/2, from 0.63 ( 0.03 s to
0.96 ( 0.05 s. This result is consistent with previous
work where systemic injections of a D2-antagonist
affected both release and reuptake (34, 40) and further
supports the idea that autoreceptor antagonists increase
evoked DA levels by decreasing reuptake in a complex
signaling process. Similarly, nomifensine delivery re-
sulted in a 187% ( 13% increase in stimulated dopa-
mine release and an increased t1/2 from 0.63( 0.03 s to
1.36( 0.05 s (Figure 8). The modulations observed due
to localized application of all three drugs is consistent
with those found for systemic injections (41).
Rapid Modulation of Dopamine Release and
Reuptake
One of the advantages of localized drug delivery is
that drug effects are observed quickly. Figure 9 demon-
strates rapid modulation of dopamine release and re-
uptake by using a D2 agonist, D2 antagonist, and
dopamine reuptake blocker. Quinpirole, a D2 agonist,
was delivered to attenuate dopamine release. As can be
seen from Figure 9A, a decrease in release is observed
immediately after the 30 s ejection. In this representative
experiment, the signal slowly returned to baseline over
10 min. Raclopride, a D2 antagonist, which blocks
autoreceptors ondopamine terminals, quickly increased
the amount of dopamine release observed by 3-fold. In
contrast to quinpirole, this effect remained steady for
over 10 min. To observe effects on dopamine reuptake,
we used the dopamine reuptake inhibitor nomifensine.
As expected from previous findings, the reuptake
blocker increased the amount of dopamine release and
slowed reuptake. This can be seen in the color plots
Figure 7. Stimulated dopamine release in an anesthetized animal before and after a localized ejection of solution containing both AP and
quinpirole. The top panels show current as a function of time, while the lower panels are two-dimensional color plots where current is shown in
false color on the potential vs time axes. The white dashed lines on the color plots indicate the voltages at which oxidation (lower lines) and
reduction (top lines) is occurring. (A) A representative baseline current trace and color plot for the stimulated release of dopamine. The black
dashed line indicates the time of stimulation. (B) Representation of iontophoretic ejection of AP and quinpirole. The black dashed line (t=0)
indicates the application of a positive current to the barrel. Themeasured signal is due solely to AP and is used to estimate the concentration of
quinpirole. Here, 2 μMAP is the average concentration across the electrode, and is equivalent to 4.4 μMquinpirole. (C) Current trace and color
plot for stimulated release 120 s after ejection seen in panel B. At the time of stimulation (black dashed line), the concentration of AP has
decreased to 2% of its original value, corresponding to a decrease in quinpirole concentration to 88 nM. The extracellular concentration of
dopamine seen in panel C is less than half the concentration initially seen in panel A. In both panels A and C the time of stimulation is indicated
by the black dashed line and t = 0 for each trace.
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shown at each point of modulation in Figure 9B. The
dopamine signal apparent in the color plots has a longer
duration once nomifensine is on board. This effect,
however, is shorter lived than the raclopride effect,
and over the course of 10 min, the signal returns to
what it was before nomifensine ejection. To seewhether
the raclopride and nomifensine effects could be re-
versed, quinpirole was reapplied, resulting in dopa-
mine release returning back to the original baseline. In
addition to demonstrating that iontophoresis can be
used toquickly and robustlymodulate dopamine release
and reuptake, it also gives insight into the different rates
of unbinding for each of these drugs. The results show
that nomifensine has a shorter-lasting effect than quin-
pirole and raclopride, consistent with studies that show
nomifensine has the fastest off rate from its binding site
to striatal membranes (when adjusted for temperature)
(42-44).
Figure 8. Stimulated dopamine release in an anesthetized animal before and after a localized ejection of solution containing both AP and
nomifensine. The top panels show current as a function of time, while the lower panels are two-dimensional color plots where current is shown
in false color on the potential vs time axes. The white dashed lines on the color plots indicate the voltages at which oxidation (lower lines) and
reduction (top lines) is occurring. (A) A representative baseline current trace and color plot for the stimulated release of dopamine. The black
dashed line is the time to stimulation. (B) Representation of iontophoretic ejection of AP and nomifensine. The black dashed line (t = 0)
indicates the application of a positive current to the barrel. Note that the measured signal is due solely to AP and is used to estimate the
concentration of nomifensine. Here, 2.5 μM AP is the average concentration across the electrode and is equivalent to 5.6 μM nomifensine.
(C) Current trace and color plot for stimulated release 120 s after ejection seen in panel B. At the time of stimulation (black dashed line), the
concentration of AP has decreased to 2% of its original value, corresponding to a decrease in nomifensine concentration to 112 nM. The
extracellular concentration of dopamine seen in panel C is significantly increased and the clearance time is also increased, indicating a change in
reuptake kinetics. In both panels A and C, the time of stimulation is indicated by the black dashed line and t = 0 for each trace.
Figure 9. Rapid modulation of DA autoreceptors using quinpirole and raclopride and dopamine transporter using nomifensine. (A)
Stimulated release of DA is recorded every 120 s, and plotted is the maximum amount of dopamine overflow recorded from each stimulation.
The circles denote the time points at which the color plots in panel B were taken. With the application of quinpirole (Q), raclopride (R), and
nomifensine (N) at the time represented with the vertical dashed line, there was a change in DA signal seen at the next stimulation. (B) Color
plots for the stimulated release of dopamine before application of any drugs and after the administration of each drug. The duration of the
dopamine signal (white dashed line) after stimulation (black dashed line) is indicative of the reuptake kinetics.
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Conclusions
The results presented characterize and validate the
use of an electroactive EOF marker for quantitative
iontophoresis using carbon-fiber microelectrode assem-
blies. Nanomolar concentrations of raclopride, quinpir-
ole, and nomifensine can be delivered bymonitoring the
coejection of the EOF marker. The effects of local
delivery of these drugs can then be monitored by
measuring electrically evoked dopamine release before
and after drug. We show that a short 30 s ejection is
sufficient to affect autoreceptor regulation and reuptake
of dopamine. Additionally, electrode placement can be
verified by iontophoresis of a dye, such as pontamine
sky blue. These experiments highlight the advantages of
iontophoresis: quick, local, and selective receptormodu-
lation. The use of carbon-fiber microelectrodes and an
EOF marker enables real-time measurements of drug
delivery, eliminating confounds from faulty ejections
and differences in doses. These modifications improve




Unless noted, all chemicals were purchased from Sigma-
Aldrich (St. Louis, MO) and used as received. Chemical
structures of the species used are shown in Figure 5. Solutions
were prepared using deionized water. A physiological buffer
solution (15 mMTRIS, 126 mMNaCl, 2.5 mMKCl, 25 mM
NaHCO3, 2.4mMCaCl2, 1.2mMNaH2PO4, 1.2mMMgCl2,
2.0 mM Na2SO4), pH 7.4, was used in all calibration experi-
ments.
Animals and Surgery
Male Sprague-Dawley rats (225-350 g; Charles River,
Wilmington, MA) were anesthetized with urethane (1.5 g/kg,
i.p.) and placed in a stereotaxic frame (Kopf, Tujunga, CA).
Holes were drilled in the skull on the right hemisphere for the
working and stimulating electrodes at coordinates selected
from the atlas of Paxinos and Watson (45). A Ag/AgCl
reference electrode was inserted in the left hemisphere. The
carbon-fiber iontophoresis probe was placed in the striatum
(AP þ1.2 mm, ML þ2.0 mm, and DV -4.5 to -6 mm). The
stimulating electrode was placed in the medial forebrain
bundle (AP -2.8 mm, ML þ1.7 mm, and DV -8.5 mm).
The carbon-fiber and stimulating electrodes were individually
adjusted in the dorsal-ventral coordinate to locate the opti-
mal locations for stimulated dopamine release.
Electrical Stimulation
An untwisted bipolar stimulating electrode (Plastics One,
Roanoke, VA) was used to stimulate dopaminergic neurons
using a pair of linear constant current stimulus isolators
(model NL80A, NeuroLog System, Digitimer Ltd., U.K.).
The stimulation train consisted of 40 biphasic pulses ((300
μA, 2 ms/phase unless otherwise noted) applied at 60Hz. The
pulses were generated by a computer and applied between the
cyclic voltammograms to avoid electrical interference.
Iontophoresis Probes
A glass capillary (part no. 624503, 0.60 mm o.d., 0.4 mm
i.d., 4 in. long, A-MSystems, Sequim,WA) was loaded with a
carbon fiber (T-650, Thornel, Amoco Corp., Greenville, SC)
that served as theworking electrode. This capillary containing
the carbon fiber was then inserted into one barrel of a 4-barrel
capillary (part no. 50644, 1 mm o.d., 0.75 mm i.d., four barrel
GF pipettes, 4 in. long, Stoelting Co., Wood Dale IL). The
four barrel assembly contained glass filaments (GF) in each
barrel that aid in filling the barrel by capillary action. The
capillarieswerebundled togetherwithheat shrink and tapered
to a sharp tip using a micropipet puller (Narashige, Tokyo,
Japan) with a two-step pull process. The protruding carbon
fiber was cut to a length between 30 and 50 μm by careful use
of a scalpel under a 10 microscope objective. The resulting
probe consists of a glass-encased carbon fiber that is 5-7 μm
indiameter and three iontophoretic barrels each about 1μmin
diameter. Before use, the barrel containing the carbon fiber
wasbackfilledwith electrolyte (4Mpotassiumacetate, 150mM
potassium chloride) and fitted with wires for electrical contact.
The remaining barrels for iontophoresis were filled with solu-
tions containing reagents to be ejected.
Electrochemical Data Acquisition and Presentation
Cyclic voltammograms were acquired using data-acquisi-
tion hardware and local software written in LabVIEW
(National Instruments, Austin, TX). The cyclic voltammetry
waveform was generated and the voltammetric signal was
acquired with a computer interface board, the PCI-6052E
(National Instruments). A PCI-6711E D/A board (National
Instruments) was used to synchronize waveform application
and data acquisition and to trigger the iontophoretic current
applied and the loop injector in the flow injection apparatus.
The voltammetric waveform was input into a custom-built
instrument for application to the electrochemical cell and
current transduction (University ofNorth Carolina at Chapel
Hill, Department of Chemistry Electronics Facility). After
data collection, background subtraction, signal averaging,
and digital filtering (low-pass filtered at 2 kHz) were all done
under software control.
For all experiments, a triangular waveform was applied
with a scan rate of 400 V s-1 with a rest potential of -0.4 V
versus a Ag/AgCl reference electrode between scans and a
linear scan to 1.3 V, followed by a scan back to the rest
potential. The scans were repeated every 100 ms, and collec-
tion was typically for 15-60 s. This large amount of data is
presented as a color plot, with the applied voltage plotted on
the ordinate, time on the abscissa, and measured current in
false color.
Iontophoresis Ejections
Characterization studies involving the effects of the neutral
marker molecule on stimulated dopamine release were done
with solutions made up at 10 mM concentrations of acetami-
nophen and 2-4(nitrophenoxy) ethanol in 5 mM NaCl. The
effects of saline were studied with 5 mMNaCl solutions. For
studies involving the modulation of stimulated dopamine
release, each barrel of the iontophoresis assembly was filled
with either raclopride tartrate salt, nomifensine maleate salt,
or quinpirole hydrochloride and theEOFmarker, usuallyAP,
at concentrations of∼10 mM each in 5 mMNaCl at pH 5.8.
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These concentrations of drug and supporting electrolyte were
chosen for the following reasons: Electrolyte is needed to
facilitate conductivity and to ensure adequate and reproduci-
ble EOF without being so high that EOF is suppressed (46);
therefore 5 mM NaCl was chosen as a compromise between
the two limits. Traditionally, drug concentrations are higher
than used here and barrels are sometimes loadedwith drugs at
concentrations of 250mM.However, given thatwe are able to
electrochemically monitor drug ejection, we determined that
10 mM is sufficiently concentrated to get observable ejection
and observe effects on stimulated dopamine release. Ejection
currents were delivered by a constant current source designed
for iontophoresis (Neurophore, Harvard Apparatus, Hollis-
ton,MA). For each barrel, an ejection current (between 5 and
40nA)was selected by evaluating ejections (30 s duration) that
gave a measurable voltammetric signal for the EOF marker
(average peak current of 5-30 nA at the peak potential in the
voltammogram). A current of 0 nA was applied between
ejections.
To minimize electrical cross-talk between the electroche-
mical and iontophoretic electrodes, both systems had a com-
mon ground. The reference electrode served as the return for
the iontophoresis currents and was tied to ground. The
potential of the working electrode was controlled by applying
the voltage to the noninverting input of the current transducer.
Calibrations
The response of the carbon fiber electrode in the ionto-
phoresis probe was calibrated in a flow injection analysis
system after in vivo use (47). The probe was positioned at the
outlet of a six-port rotary valve. A loop injector was mounted
on an actuator (Rheodyne model 7010 valve and 5701 ac-
tuator) that was used with a 12-V DC solenoid valve kit
(Rheodyne,RohnertPark,CA) to introduce the analyte to the
surface of the electrode. The linear flow velocity (1.0 cm s-1)
was controlled with a syringe infusion pump (Harvard Appa-
ratus model 940, Holliston, MA). The voltammetric current
was measured at the peak potential for each analyte that was
evaluated at four concentrations.
Capillary Electrophoresis Experiments
A home-built CE system equipped with an absorbance
detector and a 30 kV power supply was employed. Absor-
bance traces were collected using a custom written LabVIEW
program (courtesy of Professor James Jorgensen, UNC-CH).
Separations were carried out in a 50 μm diameter fused silica
capillary, 96.0 cm in total length, with the UV detector placed
87.5 cm from the inlet. Experiments were done in cationic
mode (the anode at the inlet and cathode at the outlet).
Samples were run at a concentration of 2 mM in 17 mM
PBS (phosphate-buffered saline, made up of 0.25% mono-
sodiumphosphate and0.04%disodiumphosphate) with a pH
of 5.8 as in the iontophoresis experiments. UV detection was
measured at 195 and 240 nm and electrophoretic mobilities
were calculated as previously described (24).
Histology
After animal experiments were complete, pontamine sky
bluewas loaded into one of the empty iontophoresis barrels to
mark electrode location. The dye was ejected by applying 40
nA of current for 20 min. The animals were euthanized, and
brains were removed from the skull and stored in 10%
formaldehyde for at least 3 days. Brains were coronally
sectioned into 40-50 μm thick slices with a cryostat and
visualized under a stereoscope equipped with a camera.
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